(Q38032801)

27 August 2017

Diabetes and kidney transplantation: past, present, and future (English)

1 reference

27 August 2017

kidney transplantation

1 reference

Giselle Guerra

1

1 reference

27 August 2017

Amna Ilahe

series ordinal

2

1 reference

27 August 2017

Gaetano Ciancio

series ordinal

3

1 reference

27 August 2017

1 October 2012

1 reference

27 August 2017

Current diabetes report

1 reference

27 August 2017

12

1 reference

27 August 2017

5

1 reference

27 August 2017

597-603

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-012-0306-3

27 August 2017

0 references

cites work

Prevalence of chronic kidney disease in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Risk factors for end-stage renal disease: 25-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Clinical outcome of preemptive kidney transplantation in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Diabetes mellitus after kidney transplantation in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Acute myocardial infarction and kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Renal transplantation in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Glucose control is associated with patient survival in diabetic patients after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Patient survival and cardiovascular risk after kidney transplantation: the challenge of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Cardiovascular outcomes in the outpatient kidney transplant clinic: the Framingham risk score revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Kidney transplantation in diabetic patients using cyclosporine. Five-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation1,2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Cardiovascular toxicities of immunosuppressive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Transplantation in diabetic kidney failure patients: modalities, outcomes, and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Metabolic and nutritional complications of renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Diabetes mellitus: a risk factor for delayed graft function after deceased donor kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Wound infections in renal transplant wounds: pathogenetic and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Targeting risk factors for impaired wound healing and wound complications after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Posttransplant diabetes mellitus: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Incidence and Cost of New Onset Diabetes Mellitus Among U.S. Wait-Listed and Transplanted Renal Allograft Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Posttransplantation diabetes: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Incidence and risk factors for the metabolic syndrome and posttransplant diabetes in renal transplant recipients taking tacrolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Predictors of new onset diabetes after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Mechanism of the diabetogenic action of cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

European randomised trial of dual versus triple tacrolimus-based regimens for control of acute rejection in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Post-transplant diabetes mellitus: the last 10 years with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Evaluating mechanisms of post-transplant diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Hypertension after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Survival on dialysis post-kidney transplant failure: results from the Scientific Registry of Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Belatacept: a new biologic and its role in kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0306-3

Evolution and etiology of cardiovascular diseases in renal transplant recipients

21 January 2018

1 reference

12 December 2020

Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients

1 reference

12 December 2020

Preemptive transplantation for patients with diabetes-related kidney disease

1 reference

12 December 2020

Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up

1 reference

12 December 2020

Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group

1 reference

12 December 2020

Hospitalizations for fungal infections after initiation of chronic dialysis in the United States

1 reference

12 December 2020

Simultaneous pancreas kidney transplant versus other kidney transplant options in patients with type 2 diabetes

1 reference

12 December 2020

Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis

1 reference

12 December 2020

Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study

1 reference

12 December 2020

Ambulatory blood pressure in the transition from normo- to microalbuminuria. A longitudinal study in IDDM patients

1 reference

12 December 2020

The relationship between diabetes and infectious hospitalizations in renal transplant recipients

1 reference

12 December 2020

Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation

1 reference

12 December 2020

Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression

1 reference

12 December 2020

Cardiovascular assessment of diabetic end-stage renal disease patients before renal transplantation

1 reference

12 December 2020

Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999

1 reference

12 December 2020

Cell biology. Rapamycin paradox resolved

1 reference

12 December 2020

Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease

1 reference

12 December 2020

Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study

1 reference

12 December 2020

Risk factors for development of new-onset diabetes mellitus after kidney transplantation

1 reference

12 December 2020

Effect of glycemic control on early diabetic renal lesions. A 5-year randomized controlled clinical trial of insulin-dependent diabetic kidney transplant recipients

1 reference

12 December 2020

Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients.

1 reference

12 December 2020

Metabolic syndrome, haemostasis and thrombosis

1 reference

12 December 2020

Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota

1 reference

12 December 2020

K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease

1 reference

12 December 2020

Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection

1 reference

12 December 2020

Long-term impact of pretransplant and posttransplant diabetes mellitus on kidney transplant outcomes

1 reference

12 December 2020

Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States

1 reference

12 December 2020

Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis

1 reference

12 December 2020

Randomized trial of dual antibody induction therapy with steroid avoidance in renal transplantation

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

10.1007/S11892-012-0306-3

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

0 references

1 reference